Altimmune ALT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Altimmune’s reported figures.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's enterprise value?
- Altimmune (ALT) reported enterprise value of $337.85M in Q1 2026.
- How has Altimmune's enterprise value changed year-over-year?
- Altimmune's enterprise value increased by 0.5% year-over-year, from $336.17M to $337.85M.
- What is the long-term trend for Altimmune's enterprise value?
- Over 5 years (2020 to 2025), Altimmune's enterprise value has grown at a 1.9% compound annual growth rate (CAGR), from $335.95M to $368.56M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.